Transurethral resection of the hyperplastic prostate and bladder tumor with bipolar plasmakinetic technique
Ming Hou
Abstract
Ming Hou
Abstract
Objective To evaluated the effect of simultaneous transurethral resection of benign prostatic hyperplasia (BPH) and bladder transitional cell carcinoma (BTCC) with bipolar plasmakinetic technique. Methods 23 patients with BTCC and BPH had undergone plasmakinetic resection of the bladder tumor (PKRBT) and plasmakinetic resection of the prostate (PKRP) at the same time, and had been followed up postoperatively to view the result. Results No transurethral resection syndrome occurred in those patients. The peak flow rate increased from (5.6 ± 3.4) mL/s to (20.2 ± 3.8) mL/s, the international prostate symptom score (IPSS) decreased from 23.6 ± 7.2 to 5.1 ± 0.9 at postoperative 3 months respectively and made difference (P 0.05). The following up period ranged from 5 ~ 52 months. The recurrence occurred to 3 cases without implancation at the bladder neck and prostatic urethra metastase. Conclusions PKRBT and PKRP at the same time is a safe,effective,reliable method for patients with BTCC and BPH. It can release painness of patients for second operation.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To evaluated the effect of simultaneous transurethral resection of benign prostatic hyperplasia (BPH) and bladder transitional cell carcinoma (BTCC) with bipolar plasmakinetic technique. Methods 23 patients with BTCC and BPH had undergone plasmakinetic resection of the bladder tumor (PKRBT) and plasmakinetic resection of the prostate (PKRP) at the same time, and had been followed up postoperatively to view the result. Results No transurethral resection syndrome occurred in those patients. The peak flow rate increased from (5.6 ± 3.4) mL/s to (20.2 ± 3.8) mL/s, the international prostate symptom score (IPSS) decreased from 23.6 ± 7.2 to 5.1 ± 0.9 at postoperative 3 months respectively and made difference (P 0.05). The following up period ranged from 5 ~ 52 months. The recurrence occurred to 3 cases without implancation at the bladder neck and prostatic urethra metastase. Conclusions PKRBT and PKRP at the same time is a safe,effective,reliable method for patients with BTCC and BPH. It can release painness of patients for second operation.
Key concepts: Medicine, Hyperplasia, Urology, Resection, Prostate, Neck of urinary bladder, Transurethral resection of the prostate, Prostatic urethra